Concepedia

Publication | Open Access

TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer

34

Citations

19

References

2021

Year

Abstract

Our study revealed that TTK may be a promising therapeutic target for cisplatin-resistant ovarian cancer.

References

YearCitations

Page 1